23 Jul NOVEL METHOD TO ENGINEER TRANSLANTABLE HUMAN TISSUES
Abstract
This disclosure relates to methods, polynucleotides, vectors, viral particles, cells, and systems or the engineering of human tissues. One aspect of the disclosure relates to using lineage-specific miRNA binding molecules to bias tissue lineage. Another aspect of the disclosure relates to using lineage-specific transcription factor overexpression to bias tissue lineage.
Year: 2020
Country: WO
Doc No: 2020010249